Beta-blockade in the perioperative period: Where do we stand after all the trials?

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 1, 2006, Pages 17-23

  London, Martin J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CELIPROLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; METOPROLOL; NEBIVOLOL;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG USE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LENGTH OF STAY; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; TREATMENT OUTCOME; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; META-ANALYSIS; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 33646131421     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320601000105     Document Type: Article

References (40)

1. Faraday N, Martinez EA, Scharpf RB, et al: Platelet gene polymorphisms and cardiac risk assessment in vascular surgical patients. Anesthesiology 101:1291-1297, 2004.
2. Landesberg G, Mosseri M, Zahger D, et al: Myocardial infarction after vascular surgery: The role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 37:1839-1845, 2001.
3. Le Manach Y, Perel A, Coriat P, et al: Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 102:885-891, 2005.
4. McCrath DJ, Cerboni E, Frumento RJ, et al: Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100:1576-1583, 2005.
5. Gokce N, Keaney JF Jr, Hunter LM, et al: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775, 2003.
6. London MJ, Zaugg M, Schaub MC, et al: Perioperative beta-adrenergic receptor blockade: Physiologic foundations and clinical controversies. Anesthesiology 100:170-175, 2004.
7. Kertai MD, Boersma E, Westerhout CM, et al: A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28:343-352, 2004.
8. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al: Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. The Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45:336-342, 2005.
9. Kim LJ, Martinez EA, Faraday N, et al: Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 106:2366-2371, 2002.
10. Mangano DT, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713-1720, 1996.
11. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-Risk patients undergoing vascular surgery. N Engl J Med 341:1789-1794, 1999.
12. Wallace A, Layug B, Tateo I, et al: Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88:7-17, 1998.
13. Mangano DT, Browner WS, Hollenberg M, et al: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323:1781-1788, 1990.
14. Devereaux PJ, Yusuf S, Yang H, et al: Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ 171:245-247, 2004.
15. Boersma E, Poldermans D, Bax JJ, et al: Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285:1865-1873, 2001.
16. Sear JW, Foex P, Howell SJ: Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. Br J Anaesth 84:311-315, 2000.
17. Eagle KA, Berger PB, Calkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257-1267, 2002.
18. VanDenKerkhof EG, Milne B, Parlow JL: Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: A survey of Canadian anesthesiologists. Anesth Analg 96:1558-1565, 2003.
19. London MJ, Itani KM, Perrino AC, Jr, et al: Perioperative beta-blockade: A survey of physician attitudes in the Department of Veterans Affairs. J Cardiothorac Vasc Anesth 18:14-24, 2004.
20. Grupper A, Brezis M: Resistance to use of perioperative beta-blockers: A no-man's land. Arch Intern Med 165:347, 2005.
21. Lindenauer PK, Fitzgerald J, Hoople N, et al: The potential preventability of postoperative myocardial infarction: Underuse of perioperative beta-adrenergic blockade. Arch Intern Med 164:762-766, 2004.
22. Lindenauer PK, Pekow P, Wang K, et al: Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291:2092-2099, 2004.
23. Lindenauer PK, Pekow P, Wang K, et al: Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353:349-361, 2005.
24. Lee TH, Marcantonio ER, Mangione CM, et al: Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery. Circulation 100:1043-1049, 1999.
25. Blackstone EH: Comparing apples and oranges. J Thorac Cardiovasc Surg 123:8-15, 2002.
26. Bohm M, Maack C, Wehrlen-Grandjean M, et al: Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol 92:668-676, 2003.
27. Stevens RD, Burri H, Tramer MR: Pharmacologic myocardial protection in patients undergoing noncardiac surgery: A quantitative systematic review. Anesth Analg 97:623-633, 2003.
28. Devereaux PJ, Beattie WS, Choi PT, et al: How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331:313-321, 2005.
29. London MJ, Zaugg M, Schaub MC, et al: A large trial is vital to prove perioperative beta-blockade effectiveness and safety before widespread use. Anesthesiology 101:804-805, 2004.
30. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, et al: The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: Rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 147:677-683, 2004.
31. Yang H, Raymer K, Butler R, et al: Metoprolol after vascular surgery (MaVS). Can J Anesth 51 (Suppl 1):A7, 2004.
32. Brady AR, Gibbs JS, Greenhalgh RM, et al: Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 41:602-609, 2005.
33. Zaugg M, Tagliente T, Lucchinetti E, et al: Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91:1674-1686, 1999.
34. COMMIT: Study Website: Design and Results. http://www.ctsu.ox.ac.uk/ ~ccs2/. (2005).
35. ACC/AHA/AHRQ/CMS/JCAHO Practice Advisory: Commitment to respond to COMMIT/CCS-2 Trial results. http://www.americanheart.org (2005).
36. Wijeysundera DN, Naik JS, Beattie WS: Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med 114:742-752, 2003.
37. Kamp O, Sieswerda GT, Visser CA: Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 92:344-348, 2003.
38. Witchitz S, Cohen-Solal A, Dartois N, et al: Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group. Am J Cardiol 85:1467-1471, 2000.
39. Tardif J-C: Ivabradine in clinical practice: benefits of If inhibition. Eur Heart J Suppl 7:H29-32, 2005.
40. Boyce SW, Bartels C, Bolli R, et al: Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: Results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg 126:420-427, 2003.